NYSE:CLB Core Laboratories (CLB) Stock Forecast, Price & News $24.90 -1.30 (-4.96%) (As of 06/9/2023 ET) Add Compare Share Share Today's Range$24.80▼$26.0150-Day Range$20.55▼$26.2052-Week Range$13.19▼$27.12Volume436,003 shsAverage Volume378,362 shsMarket Capitalization$1.16 billionP/E Ratio49.80Dividend Yield0.16%Price Target$22.30 ProfileProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Core Laboratories MarketRank™ ForecastAnalyst RatingReduce1.33 Rating ScoreUpside/Downside10.4% Downside$22.30 Price TargetShort InterestHealthy8.37% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.39Based on 5 Articles This WeekInsider TradingN/AProj. Earnings Growth36.25%From $0.80 to $1.09 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.17 out of 5 starsOils/Energy Sector172nd out of 252 stocksOil & Gas Field Services, Not Elsewhere Classified Industry14th out of 20 stocks 0.7 Analyst's Opinion Consensus RatingCore Laboratories has received a consensus rating of Sell. The company's average rating score is 1.33, and is based on no buy ratings, 1 hold rating, and 2 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $22.30, Core Laboratories has a forecasted downside of 10.4% from its current price of $24.90.Amount of Analyst CoverageCore Laboratories has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted8.37% of the float of Core Laboratories has been sold short.Short Interest Ratio / Days to CoverCore Laboratories has a short interest ratio ("days to cover") of 9.7.Change versus previous monthShort interest in Core Laboratories has recently decreased by 26.05%, indicating that investor sentiment is improving significantly. Previous Next 1.7 Dividend Strength Dividend YieldCore Laboratories has a dividend yield of 0.16%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCore Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Core Laboratories is 8.00%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Core Laboratories will have a dividend payout ratio of 3.67% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CLB. Previous Next 2.4 News and Social Media Coverage News SentimentCore Laboratories has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Oils/Energy companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Core Laboratories this week, compared to 2 articles on an average week.MarketBeat Follows1 people have added Core Laboratories to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Core Laboratories insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.60% of the stock of Core Laboratories is held by insiders.Percentage Held by Institutions97.44% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 4.4 Earnings and Valuation Earnings GrowthEarnings for Core Laboratories are expected to grow by 36.25% in the coming year, from $0.80 to $1.09 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Core Laboratories is 49.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 144.33.Price to Earnings Ratio vs. SectorThe P/E ratio of Core Laboratories is 49.80, which means that it is trading at a less expensive P/E ratio than the Oils/Energy sector average P/E ratio of about 50.10.Price to Earnings Growth RatioCore Laboratories has a PEG Ratio of 0.65. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioCore Laboratories has a P/B Ratio of 6.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Core Laboratories (NYSE:CLB) StockCore Laboratories, Inc. provides proprietary and patented reservoir description and production enhancement services. The company was founded on May 1, 2023 and is headquartered in Houston, TX.Read More Receive CLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address CLB Stock News HeadlinesJune 7, 2023 | finance.yahoo.comCore Laboratories (NYSE:CLB) Is Finding It Tricky To Allocate Its CapitalJune 4, 2023 | benzinga.comCore Laboratories Stock (NYSE:CLB), Insider Trading ActivityJune 10, 2023 | Legacy Research (Affiliate) (Ad)Sell Every Stock, Except ONE (Ticker Revealed)We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.June 4, 2023 | americanbankingnews.comCore Laboratories (NYSE:CLB) Now Covered by Analysts at StockNews.comMay 27, 2023 | americanbankingnews.comCore Laboratories (NYSE:CLB) Coverage Initiated by Analysts at StockNews.comMay 26, 2023 | finance.yahoo.comCore Laboratories (CLB) Up 1.4% Since Last Earnings Report: Can It Continue?May 24, 2023 | americanbankingnews.comCore Laboratories (NYSE:CLB) Shares Up 6.1%May 22, 2023 | finance.yahoo.comCore Laboratories Inc.'s (NYSE:CLB) Earnings Haven't Escaped The Attention Of InvestorsJune 10, 2023 | Legacy Research (Affiliate) (Ad)“You need at least $100 of this asset – and it’s NOT gold” – Dr. Nomi Prin$100 is all you need… Former Goldman Sachs managing director Dr. Nomi Prins has identified an investment she’s calling ‘the world’s hardest asset’ – and she’s recommending it to friends, family, and followers.May 21, 2023 | americanbankingnews.comCore Laboratories (NYSE:CLB) Research Coverage Started at StockNews.comMay 12, 2023 | seekingalpha.comCore Laboratories: Green Shoots, But Too Far Down The RoadMay 5, 2023 | finance.yahoo.comCore Laboratories (NYSE:CLB) sheds US$51m, company earnings and investor returns have been trending downwards for past five yearsMay 4, 2023 | americanbankingnews.comCore Laboratories (NYSE:CLB) Receives New Coverage from Analysts at StockNews.comMay 3, 2023 | americanbankingnews.comCore Laboratories (NYSE:CLB) PT Raised to $19.00 at Piper SandlerMay 2, 2023 | americanbankingnews.comCore Laboratories (NYSE:CLB) Price Target Increased to $25.00 by Analysts at Stifel NicolausMay 1, 2023 | msn.comPiper Sandler Maintains Core Laboratories N.V. (CLB) Neutral RecommendationMay 1, 2023 | markets.businessinsider.comThe Latest Analyst Ratings for Core LaboratoriesApril 28, 2023 | msn.comStifel Maintains Core Laboratories N.V. (CLB) Hold RecommendationApril 28, 2023 | finance.yahoo.comCore Laboratories (CLB) Q1 2023 Earnings Call TranscriptApril 28, 2023 | msn.comCore Laboratories N.V. (CLB) Declares $0.01 DividendApril 27, 2023 | benzinga.comCore Lab shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.April 26, 2023 | finance.yahoo.comCORE LAB REPORTS FIRST QUARTER 2023 RESULTS:April 26, 2023 | finance.yahoo.comCore Laboratories (CLB) Q1 Earnings and Revenues Surpass EstimatesApril 25, 2023 | americanbankingnews.comReviewing Superior Energy Services (OTCMKTS:SPNX) & Core Laboratories (NYSE:CLB)April 24, 2023 | americanbankingnews.comCore Laboratories (CLB) to Release Earnings on WednesdayApril 20, 2023 | americanbankingnews.comCore Laboratories (NYSE:CLB) Shares Gap Down to $22.31April 20, 2023 | americanbankingnews.comCore Laboratories (NYSE:CLB) Rating Lowered to Underperform at Bank of AmericaSee More Headlines CLB Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLB Company Calendar Last Earnings4/26/2023Ex-Dividend for 5/30 Dividend5/05/2023Dividend Payable5/30/2023Today6/10/2023Next Earnings (Estimated)7/26/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Oil & gas field services, not elsewhere classified Sub-IndustryN/A SectorOils/Energy Current SymbolNYSE:CLB CUSIPN/A CIK1000229 Webwww.corelab.com Phone(713) 328-2673FaxN/AEmployees3,600Year Founded1936Price Target and Rating Average Stock Price Forecast$22.30 High Stock Price Forecast$26.00 Low Stock Price Forecast$19.00 Forecasted Upside/Downside-10.4%Consensus RatingReduce Rating Score (0-4)1.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)$0.50 Trailing P/E Ratio49.80 Forward P/E Ratio31.13 P/E Growth0.65Net Income$19.45 million Net Margins4.72% Pretax Margin7.17% Return on Equity15.23% Return on Assets4.90% Debt Debt-to-Equity Ratio0.90 Current Ratio2.38 Quick Ratio1.68 Sales & Book Value Annual Sales$489.73 million Price / Sales2.37 Cash Flow$0.91 per share Price / Cash Flow27.25 Book Value$4.07 per share Price / Book6.12Miscellaneous Outstanding Shares46,680,000Free Float46,402,000Market Cap$1.16 billion OptionableOptionable Beta2.67 Social Links Key ExecutivesLawrence V. BrunoChairman, President & Chief Executive OfficerChristopher S. HillChief Financial Officer & Senior Vice PresidentMark Damian TattoliSecretary, Senior Vice President & General CounselKevin G. DanielsChief Accounting Officer & Vice PresidentJ. Donald DumasSVP-Production Enhancement & Business DevelopmentKey CompetitorsHelix Energy Solutions GroupNYSE:HLXProPetroNYSE:PUMPRPCNYSE:RESProFracNASDAQ:PFHCOceaneering InternationalNYSE:OIIView All CompetitorsInstitutional OwnershipToroso Investments LLCSold 999 shares on 5/23/2023Ownership: 0.081%Ameriprise Financial Inc.Bought 565,344 shares on 5/22/2023Ownership: 1.934%Trivant Custom Portfolio Group LLCBought 2,223 shares on 5/19/2023Ownership: 0.005%JPMorgan Chase & Co.Bought 2,898 shares on 5/18/2023Ownership: 0.052%Advisory Services Network LLCSold 1,063 shares on 5/17/2023Ownership: 0.003%View All Institutional Transactions CLB Stock - Frequently Asked Questions Should I buy or sell Core Laboratories stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 2 sell ratings and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" CLB shares. View CLB analyst ratings or view top-rated stocks. What is Core Laboratories' stock price forecast for 2023? 3 equities research analysts have issued twelve-month target prices for Core Laboratories' stock. Their CLB share price forecasts range from $19.00 to $26.00. On average, they predict the company's share price to reach $22.30 in the next year. This suggests that the stock has a possible downside of 10.4%. View analysts price targets for CLB or view top-rated stocks among Wall Street analysts. How have CLB shares performed in 2023? Core Laboratories' stock was trading at $20.27 at the beginning of 2023. Since then, CLB shares have increased by 22.8% and is now trading at $24.90. View the best growth stocks for 2023 here. Are investors shorting Core Laboratories? Core Laboratories saw a decrease in short interest in May. As of May 15th, there was short interest totaling 3,860,000 shares, a decrease of 26.1% from the April 30th total of 5,220,000 shares. Based on an average daily trading volume, of 399,100 shares, the days-to-cover ratio is presently 9.7 days. Approximately 8.4% of the shares of the company are short sold. View Core Laboratories' Short Interest. When is Core Laboratories' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 26th 2023. View our CLB earnings forecast. How were Core Laboratories' earnings last quarter? Core Laboratories Inc. (NYSE:CLB) posted its earnings results on Wednesday, April, 26th. The oil and gas company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.14 by $0.06. The oil and gas company had revenue of $128.36 million for the quarter, compared to analyst estimates of $126.26 million. Core Laboratories had a net margin of 4.72% and a trailing twelve-month return on equity of 15.23%. How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories? Core Laboratories declared a quarterly dividend on Wednesday, April 26th. Shareholders of record on Monday, May 8th will be paid a dividend of $0.01 per share on Tuesday, May 30th. This represents a $0.04 dividend on an annualized basis and a yield of 0.16%. The ex-dividend date is Friday, May 5th. Read our dividend analysis for CLB. What ETFs hold Core Laboratories' stock? ETFs with the largest weight of Core Laboratories (NYSE:CLB) stock in their portfolio include Cultivar ETF (CVAR), Invesco Dynamic Oil & Gas Services ETF (PXJ), Invesco S&P SmallCap Energy ETF (PSCE), SPDR S&P Oil & Gas Equipment & Services ETF (XES), iShares U.S. Oil Equipment & Services ETF (IEZ), VanEck Oil Services ETF (OIH), Direxion Daily Oil Services Bull 2X Shares (ONG) and Vanguard Energy ETF (VDE). Is Core Laboratories a good dividend stock? Core Laboratories (NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.16%. The dividend payout ratio is 8.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CLB will have a dividend payout ratio of 3.67% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for CLB. What guidance has Core Laboratories issued on next quarter's earnings? Core Laboratories updated its second quarter 2023 earnings guidance on Thursday, April, 27th. The company provided earnings per share (EPS) guidance of $0.20-$0.24 for the period, compared to the consensus EPS estimate of $0.21. The company issued revenue guidance of $130.00 million-$135.00 million, compared to the consensus revenue estimate of $132.83 million. What is David M. Demshur's approval rating as Core Laboratories' CEO? 60 employees have rated Core Laboratories Chief Executive Officer David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among the company's employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD). What is Core Laboratories' stock symbol? Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB." Who are Core Laboratories' major shareholders? Core Laboratories' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.33%), Boston Trust Walden Corp (4.49%), State Street Corp (2.74%), Ameriprise Financial Inc. (1.93%), Van ECK Associates Corp (1.83%) and Dimensional Fund Advisors LP (1.70%). View institutional ownership trends. How do I buy shares of Core Laboratories? Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Core Laboratories' stock price today? One share of CLB stock can currently be purchased for approximately $24.90. How much money does Core Laboratories make? Core Laboratories (NYSE:CLB) has a market capitalization of $1.16 billion and generates $489.73 million in revenue each year. The oil and gas company earns $19.45 million in net income (profit) each year or $0.50 on an earnings per share basis. How many employees does Core Laboratories have? The company employs 3,600 workers across the globe. How can I contact Core Laboratories? Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The official website for the company is www.corelab.com. The oil and gas company can be reached via phone at (713) 328-2673 or via email at investor.relations@corelab.com. This page (NYSE:CLB) was last updated on 6/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.